SCHEMBL30765259

SCHEMBL30765259

CS(=O)(=O)c1ccc(-c2cc3nccc(-c4cccc(C(=O)N5CCC(F)(F)CC5)c4)c3o2)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37
CYP3A4 P08684 6/20 0.36
HPGD P15428 4/20 0.36
ABL1 P00519 3/20 0.36
BCR P11274 3/20 0.36
TSHR P16473 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 3/20 0.36
FYN P06241 1/20 0.36
CYP2D6 P10635 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP1A2 P05177 1/20 0.35
LRRK2 Q5S007 1/20 0.35
NAMPT P43490 1/20 0.35
LIPC P11150 1/20 0.34
LIPG Q9Y5X9 1/20 0.34
USP2 O75604 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30765312 0.91 HPGD (0.41) CCNT1CDK9CYP3A4HPGDABL1
SCHEMBL27261503 0.90 CCNT1 (0.46) CCNT1CDK9CYP3A4HPGDTSHR
SCHEMBL30765359 0.85 HSD17B10 (0.44) CCNT1CDK9HPGDALDH1A1HSD17B10
SCHEMBL30765169 0.84 CCNT1 (0.37) CCNT1CDK9HPGDHSD17B10FYN
SCHEMBL27261385 0.83 HPGD (0.37) CCNT1CDK9CYP3A4HPGDABL1
SCHEMBL27261616 0.82 CDK9 (0.31) CDK9
SCHEMBL30765346 0.82 PDE4B (0.36) CCNT1CDK9PIK3CD
SCHEMBL30765217 0.81 MAP3K7 (0.34) CCNT1CDK9FYNLRRK2
SCHEMBL30765305 0.81 ALOX5AP (0.41) CCNT1CDK9CYP3A4CYP2C9CYP2C19
SCHEMBL30765241 0.81 ALOX5AP (0.41) CCNT1CDK9CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024033280-A1 FUROPYRIDIN AND FUROPYRIMIDIN, INHIBITORS OF PI4K, FOR USE IN THE TREATMENT OF PARASITE INFECTION AND MALARIA MERCK PATENT GMBH (DE) 2024-02-15 WO disclosed